1. Home
  2. WMK vs NRIX Comparison

WMK vs NRIX Comparison

Compare WMK & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Weis Markets Inc.

WMK

Weis Markets Inc.

HOLD

Current Price

$67.93

Market Cap

1.8B

ML Signal

HOLD

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

HOLD

Current Price

$15.53

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WMK
NRIX
Founded
1912
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Food Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.6B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
WMK
NRIX
Price
$67.93
$15.53
Analyst Decision
Strong Buy
Analyst Count
0
12
Target Price
N/A
$30.58
AVG Volume (30 Days)
136.1K
968.3K
Earning Date
03-12-2026
04-10-2026
Dividend Yield
1.99%
N/A
EPS Growth
N/A
N/A
EPS
3.65
N/A
Revenue
$4,714,573,000.00
$76,987,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$26.32
P/E Ratio
$18.75
N/A
Revenue Growth
0.01
99.31
52 Week Low
$59.99
$8.18
52 Week High
$90.23
$22.50

Technical Indicators

Market Signals
Indicator
WMK
NRIX
Relative Strength Index (RSI) 54.71 50.50
Support Level $68.06 $14.61
Resistance Level $70.31 $16.47
Average True Range (ATR) 1.84 0.89
MACD 0.53 0.07
Stochastic Oscillator 82.41 66.97

Price Performance

Historical Comparison
WMK
NRIX

About WMK Weis Markets Inc.

Weis Markets Inc is a U.S.-based company that is principally engaged in retailing food products in Pennsylvania and surrounding states. The company's products mainly belong to the following categories: center-store goods, fresh goods, pharmacy services, fuel, and others. The center-store goods include groceries, dairy products, frozen foods, alcoholic beverages, and general merchandise items. The fresh goods include meats, seafood, floral, prepared foods, and bakery products. The center-store goods and fresh goods jointly account for the majority of the company's total revenue.

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

Share on Social Networks: